Rocket Pharmaceuticals (RCKT) Total Current Liabilities (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted Total Current Liabilities of $24.5 million for Q1 2026, down 19.0% sequentially from $30.2 million in Q4 2025, and down 30.71% YoY from $35.3 million in Q1 2025.
Rocket Pharmaceuticals (RCKT) Total Current Liabilities (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported Total Current Liabilities for 13 years, with the latest figure at $24.5 million in Q1 2026.
- Quarterly Total Current Liabilities fell 30.71% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.5 million (down 30.71% YoY) and the FY2025 annual result came in at $30.2 million, down 25.75% from the prior year.
- Total Current Liabilities eased to $24.5 million in Q1 2026 per RCKT's latest filing, from $30.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $48.5 million in Q4 2023 and troughed at $22.6 million in Q1 2022.
- A 5-year average of $34.1 million and a median of $33.5 million in 2023 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 76.7% in 2022, down 44.26% in 2022.
- Over 5 years, Total Current Liabilities stood at $39.2 million in 2022, then gained by 23.84% to $48.5 million in 2023, then slipped by 16.12% to $40.7 million in 2024, then declined by 25.75% to $30.2 million in 2025, then fell by 19.0% to $24.5 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $24.5 million, $30.2 million, and $31.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - | 31.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.32 Mn |
| Mar 31, 2026 | 24.47 Mn |
| Dec 31, 2025 | 30.21 Mn |
| Sep 30, 2025 | 31.17 Mn |
| Jun 30, 2025 | 43.40 Mn |
| Mar 31, 2025 | 35.31 Mn |
| Dec 31, 2024 | 40.68 Mn |
| Sep 30, 2024 | 39.98 Mn |
| Jun 30, 2024 | 37.59 Mn |
| Mar 31, 2024 | 32.96 Mn |
| Dec 31, 2023 | 48.51 Mn |
| Sep 30, 2023 | 33.48 Mn |
| Jun 30, 2023 | 34.35 Mn |
| Mar 31, 2023 | 31.21 Mn |
| Dec 31, 2022 | 39.17 Mn |
| Sep 30, 2022 | 30.18 Mn |
| Jun 30, 2022 | 24.29 Mn |
| Mar 31, 2022 | 22.57 Mn |
| Dec 31, 2021 | 22.17 Mn |
| Sep 30, 2021 | 24.49 Mn |